Discover how biomarker strategies are transforming drug development for neurodegenerative diseases.
This on-demand webinar explores:
Gain insights into recent advancements in biomarker-driven drug approvals and their impact on Alzheimer’s, Parkinson’s, and ALS treatment strategies.
Register to access the on-demand recording.